; and (D) such other information as may be specified in regulation or guidance issued by the Secretary. (3) Rule of construction This section shall not be construed to require the inclusion in any report under this section any consumer complaint that concerns solely efficacy and does not contain any information about an adverse event. (d) Limitation with respect to adverse event reports Section 756 shall apply with respect to the submission of an adverse event report in compliance with subsection (a). (e) Contact information The label of a cosmetic product shall bear the domestic address, and either the domestic telephone number or electronic contact information, through which the responsible person may receive a report of an adverse event. (f) Availability to States The Secretary shall make records submitted under this section available to any State, upon request, to the extent permissible under the laws governing disclosure of information by the Secretary. Information disclosed to a State that is exempt from disclosure under section 552(b)(4) of title 5, United States Code, shall be treated as a trade secret and confidential information by the State. Such State and its employees in possession of such information shall be subject to the same laws governing information disclosure as employees of the Food and Drug Administration. (g) Protection of information A serious adverse event report submitted to the Secretary under subsection (a), including any new medical information submitted under paragraph (2) of such subsection, or an adverse event report voluntarily submitted to the Secretary, shall be considered to be a safety report under section 756 and may be accompanied by a statement, which shall be a part of any report that is released for public disclosure, that denies that the report or the records constitute an admission that the product involved caused or contributed to the adverse event. (h) Effective dates (1) Serious adverse events The requirement under this section to report serious adverse events shall